Stay updated with breaking news from Single Agent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These OS results build on positive data previously reported from KEYNOTE-811 that supported its FDA-approved indication ...
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The
Global Phase 3 studies started for bomedemstat , nemtabrutinib , MK-2870 and MK-5684 Comprehensive clinical development programs being initiated for each investigational candidate Demonstrates...
New formulation showed non-inferiority to intravenous administration in fourth positive Phase 3 study in RYBREVANT® clinical program
/PRNewswire/ -- Florida Cancer Specialists & Research Institute (FCS) physicians will present at the Society for Immunotherapy of Cancer Annual Meeting this...